1. Iohexol in Coronary Angiography
- Author
-
E. Andrew, O. S. Ørjavik, M. Skrede, and O. Orning
- Subjects
Adult ,Male ,Coronary angiography ,medicine.medical_specialty ,Iohexol ,Contrast Media ,Blood Pressure ,030204 cardiovascular system & hematology ,Coronary Angiography ,Double blind ,Random Allocation ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Heart Rate ,Triiodobenzoic Acids ,Internal medicine ,Heart rate ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Aged ,Radiological and Ultrasound Technology ,Meglumine ,business.industry ,Isopaque coronar ,Arrhythmias, Cardiac ,Metrizoic Acid ,Middle Aged ,Contrast medium ,Blood pressure ,Cardiology ,Drug Evaluation ,Iodobenzoates ,Female ,business ,medicine.drug - Abstract
Iohexol 350 mg I/ml (Omnipaque) was compared with the routine contrast medium meglumine, Na-Ca-metrizoate 370 mg I/ml (Isopaque Coronar) in coronary angiography in 30 patients. A randomized, double blind, cross-over design was employed. Angiographic image quality, ECG, heart rate, aortic blood pressure and adverse reactions were recorded. Excellent image quality was obtained with both media. Except for one single event of hypotension, only few and minor changes in the parameters measured were recorded. No distinct difference between the two media was found. Iohexol seems to be suitable for selective coronary angiography.
- Published
- 1984
- Full Text
- View/download PDF